UAS regulatory sequences drive expression of an inverted repeat.
Clonal expression of Atg1JF02273 under the control of Scer\GAL4Act5C.PU in the larval fat body leads to smaller cells in starved individuals, but not in well fed individuals, as compared to controls.
Flies expressing Atg1JF02273 under the control of Scer\GAL4Mef2.PU have similar lifespan, locomotion and mitochondrial structure as wild-type controls.
Expression of Atg1JF02273 under the control of Scer\GAL4phm.PO leads to massive accumulation of lipid droplets in the prothoracic gland cells of third instar larvae.
Expression of Atg1JF02273 in muscle under the control of Scer\GAL4Mef2.PU results in significant hyperglycaemia.
Expression of Atg1JF02273 under the control of Scer\GAL4Myo31DF-NP0001 results in significantly delayed midgut degradation after pupariation, with increased size of the midgut and gastric caeca 4 hrs after puparium formation, and decreased autophagy 2 hrs after puparium formation, as compared to controls.
Expression of Atg1JF02273 under the control of Scer\GAL4cg.PU results in a decrease in starvation-induced autophagy in the larval fat body, as compared to controls.
Expression of Atg1JF02273 under the control of Scer\GAL4Mef2.PR is able to completely suppress the formation of autophagosomes in the muscles of both untreated and chloroquine-treated larvae starved on low-nutrient food for 6 hours.
Glycogen breakdown occurs normally in the muscles of larvae expressing Atg1JF02273 under the control of Scer\GAL4Mef2.PR starved on low-nutrient food for 24 hours, but the rate of breakdown is reduced compared to controls.
After 3 or 6 hours of starvation, expression of Atg1JF02273 under the control of Scer\GAL4Mef2.PR significantly improves the crawling defects seen in chloroquine-treated larvae compared to controls. After 6 hours starvation, crawling is negatively affected in the absence of chloroquine treatment. In well-fed larvae there is little difference between crawling time compared to controls, either in the presence or absence of chloroquine.
Expression of Atg1JF02273 using Scer\GAL4Act5C.PP results in basal autophagy defects in larval fat body cell somatic clones.
Expression of Atg1JF02273 using Scer\GAL4Cg.PA causes a decrease in starvation-induced autophagic response in the fat body of wandering third instar larvae compared with wild-type.
Expression of Atg1JF02273 via Scer\GAL4HCH.Hand causes a decline in cardiac performance.
Expression of Atg1JF02273 via Scer\GAL4Mef2.PR causes mitochondrial abnormalities and degeneration in skeletal muscle.
Atg1JF02273, Scer\GAL4NP0001 has decreased cell death | P-stage phenotype, suppressible by mTorHMS00904, Scer\GAL4NP0001
Atg1JF02273, Scer\GAL4NP0001 has abnormal size | P-stage phenotype, suppressible by mTorHMS00904, Scer\GAL4NP0001
Atg1JF02273, Scer\GAL4elav.PU is an enhancer of abnormal heat stress response | adult stage phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4GMR16F10 is a non-enhancer of increased cell number | P-stage phenotype of BacA\p35UAS.cHa, Scer\GAL4GMR16F10
Scer\GAL4Act5C.PU/Atg1JF02273 is a non-enhancer of decreased cell size | larval stage | somatic clone phenotype of vapKS67
Atg1JF02273, Scer\GAL4nub-AC-62 is a suppressor of visible | adult stage phenotype of Scer\GAL4nub-AC-62, synrUAS.ORF.GW.Tag:HA
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of abnormal heat stress response | adult stage phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of paralytic | adult stage | heat sensitive phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of abnormal locomotor behavior | third instar larval stage phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4elav.PU is a suppressor | partially of abnormal locomotor behavior | adult stage phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of visible | adult stage phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Scer\GAL4GMR.PU, Atg1JF02273 is a suppressor of visible phenotype of Atg13UAS.EGFP, Atg1UAS.Tag:MYC, Scer\GAL4GMR.PU
Atg1JF02273, Scer\GAL4NP0001 is a suppressor of decreased cell death | P-stage phenotype of Scer\GAL4NP0001, mTorHMS00904
Atg1JF02273, Scer\GAL4NP0001 is a suppressor of abnormal size | third instar larval stage phenotype of Scer\GAL4NP0001, mTorHMS00904
Scer\GAL4Act5C.PU/Atg1JF02273 is a non-suppressor of decreased cell size | somatic clone | larval stage phenotype of vapKS67
Atg1JF02273/Scer\GAL4GMR.PU is a non-suppressor of visible | adult stage phenotype of Pink1GMR.Tag:Mito(Tom20),GFP, parkGMR.Tag:FLAG
Atg1JF02273/Scer\GAL4GMR.PU is a non-suppressor of abnormal eye color | adult stage phenotype of Pink1GMR.Tag:Mito(Tom20),GFP, parkGMR.Tag:FLAG
Atg1JF02273, Scer\GAL4salm.EPv is a non-suppressor of visible phenotype of Scer\GAL4salm.EPv, Tcs5RNAi.UAS.462
Atg1JF02273, Scer\GAL4NP0001 has embryonic/larval midgut | P-stage phenotype, suppressible by mTorHMS00904, Scer\GAL4NP0001
Atg1JF02273, Scer\GAL4NP0001 has gastric caecum | P-stage phenotype, suppressible by mTorHMS00904, Scer\GAL4NP0001
Atg1JF02273, Scer\GAL4Ugt36A1.PK is an enhancer of nephrocyte phenotype of Coq2RNAi.UAS.cUa, Scer\GAL4Ugt36A1.PK
Atg1JF02273, Scer\GAL4GMR16F10 is a non-enhancer of optic neuroblast | P-stage | increased number phenotype of BacA\p35UAS.cHa, Scer\GAL4GMR16F10
Scer\GAL4Act5C.PU/Atg1JF02273 is a non-enhancer of embryonic/larval fat body | larval stage | somatic clone phenotype of vapKS67
Atg1JF02273, Scer\GAL4nub-AC-62 is a suppressor of wing phenotype of Scer\GAL4nub-AC-62, synrUAS.ORF.GW.Tag:HA
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of wing phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of mitochondrion | third instar larval stage phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of mitochondrion | third instar larval stage | decreased number phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Atg1JF02273, Scer\GAL4elav.PU is a suppressor of embryonic/larval neuromuscular junction | third instar larval stage phenotype of Hsc70-5KK100233, Scer\GAL4elav.PU
Scer\GAL4GMR.PU, Atg1JF02273 is a suppressor of eye phenotype of Atg13UAS.EGFP, Atg1UAS.Tag:MYC, Scer\GAL4GMR.PU
Atg1JF02273, Scer\GAL4NP0001 is a suppressor of gastric caecum | third instar larval stage phenotype of Scer\GAL4NP0001, mTorHMS00904
Atg1JF02273, Scer\GAL4NP0001 is a suppressor of embryonic/larval midgut | third instar larval stage phenotype of Scer\GAL4NP0001, mTorHMS00904
Scer\GAL4Act5C.PU/Atg1JF02273 is a non-suppressor of embryonic/larval fat body | somatic clone | larval stage phenotype of vapKS67
Atg1JF02273/Scer\GAL4GMR.PU is a non-suppressor of eye phenotype of Pink1GMR.Tag:Mito(Tom20),GFP, parkGMR.Tag:FLAG
Atg1JF02273, Scer\GAL4salm.EPv is a non-suppressor of first posterior wing cell phenotype of Scer\GAL4salm.EPv, Tcs5RNAi.UAS.462
Expression of Atg1JF02273 completely suppresses the eye degeneration seen when Atg1Scer\UAS.T:Hsap\MYC and Atg13Scer\UAS.T:Avic\GFP-EGFP are co-expressed under the control of Scer\GAL4GMR.PU at 18[o]C.
Co-expression of Atg1JF02273 and TorHMS00904 under the control of Scer\GAL4Myo31DF-NP0001 restores autophagy and gastric caeca contraction to levels similar to those seen in controls.
The reduction in the distance between wing veins 3 and 4 that is seen in animals expressing PrpkdsRNA.Scer\UAS.462 under the control of Scer\GAL4salm.EPv is not suppressed if they are also co-expressing Atg1JF02273.
In contrast to the expression of either transgene alone, glycogen breakdown is disrupted in the muscles of larvae co-expressing Atg1JF02273 and GlyPNIG.7254R under the control of Scer\GAL4Mef2.PR and starved on low-nutrient food for 24 hours.